Related references
Note: Only part of the references are listed.Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
Nicole L. Kallewaard et al.
CELL (2016)
Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus
Karuppiah Muthumani et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cells
Xiaodong Xiao et al.
MABS (2016)
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Hadi M. Yassine et al.
NATURE MEDICINE (2015)
Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy
Seleeke Flingai et al.
SCIENTIFIC REPORTS (2015)
Electroporation-enhanced delivery of nucleic acid vaccines
Kate E. Broderick et al.
EXPERT REVIEW OF VACCINES (2015)
pH-dependent Binding Engineering Reveals an FcRn Affinity Threshold That Governs IgG Recycling
M. Jack Borrok et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A Broadly Neutralizing Human Monoclonal Antibody Directed against a Novel Conserved Epitope on the Influenza Virus H3 Hemagglutinin Globular Head
Ebony Benjamin et al.
JOURNAL OF VIROLOGY (2014)
Rapid development of broadly influenza neutralizing antibodies through redundant mutations
Leontios Pappas et al.
NATURE (2014)
Immunological assessment of influenza vaccines and immune correlates of protection
Adrian Reber et al.
EXPERT REVIEW OF VACCINES (2013)
Broad protection against influenza infection by vectored immunoprophylaxis in mice
Alejandro B. Balazs et al.
NATURE BIOTECHNOLOGY (2013)
Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza
Maria P. Limberis et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Synthetic DNA vaccines: improved vaccine potency by electroporation anc co-delivered genetic adjuvants
Seleeke Flingai et al.
FRONTIERS IN IMMUNOLOGY (2013)
Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus et al.
SCIENCE (2012)
Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
Mark L. Bagarazzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
Davide Corti et al.
SCIENCE (2011)
CURRENT CONCEPTS Influenza Vaccines for the Future
Linda C. Lambert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
Gayathri Bommakanti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
Aeron C. Hurt et al.
JOURNAL OF VIROLOGY (2009)
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Noelle-Angelique M. Molinari et al.
VACCINE (2007)
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
Arnold S. Monto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Variation and infectivity neutralization in influenza
Marcel Knossow et al.
IMMUNOLOGY (2006)
Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection
MD de Jong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
E Traggiai et al.
NATURE MEDICINE (2004)
Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60
H Jin et al.
VIROLOGY (2003)
Share Paper
